Stocktoria
Sintx Technologies, Inc. SINT
Nasdaq · XNAS · stock · Surgical & Medical Instruments & Apparatus · website · IPO 2014-02-11
Sintx Technologies, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $1.0M | $2.9M | $2.6M | $1.6M | $606,000 |
| Gross profit | $461,000 | $2.1M | $1.8M | $1.3M | $157,000 |
| R&D expense | $4.6M | $5.2M | $8.7M | $6.5M | $5.9M |
| Operating income | -$10.7M | -$14.0M | -$13.4M | -$11.3M | -$10.6M |
| Net income | -$10.4M | -$11.0M | -$8.3M | -$12.0M | -$9.3M |
| EPS (diluted) | $-6.16 | $-15.19 | $-624.47 | $-60.81 | $-39.91 |
| Operating cash flow | -$8.6M | -$8.6M | -$14.1M | -$10.3M | -$10.1M |
| Free cash flow | -$8.8M | -$9.3M | -$14.6M | -$11.7M | -$13.9M |
| Cash & equivalents | $4.1M | $3.6M | $3.3M | $6.2M | $14.3M |
| Inventory | $825,000 | $502,000 | $888,000 | $737,000 | $597,000 |
| Total assets | $9.5M | $9.4M | $15.4M | $15.8M | $21.8M |
| Total liabilities | $6.6M | $5.5M | $6.6M | $10.1M | $4.6M |
| Shareholders' equity | $2.9M | $3.9M | $8.8M | $5.7M | $17.2M |
Source: SEC EDGAR filings · CIK 0001269026 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.